{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T03:45:21Z","timestamp":1789530321111,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Airway bacterial infections are frequent in severe asthma and are often under-appreciated as contributors to symptoms and exacerbations. We report our experience using integrative diagnostic methods to identify ciliary motility disorders as contributors to neutrophilic exacerbations in patients with severe asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Targeted exome sequencing for primary ciliary dyskinesia (PCD) was performed on 52 patients with severe asthma who met predefined criteria (\u2265\u20093 respiratory infections or intense sputum neutrophilia, within a 2-year period, along with evidence of type 2 inflammation, including peripheral or sputum eosinophilia, elevated fractional exhaled nitric oxide (FeNO), or elevated serum immunoglobulin E), and without other obvious immunodeficiencies. A subset of patients with PCD-related gene variant(s) underwent ciliary beat frequency (CBF) analysis from nasal epithelial brushings (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200920 with analyzable data), nasal nitric oxide (nNO) measurement (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200915), and T1\/2\/17 sputum cytokine assays (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200918).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 52 patients (mean age 54.2\u2009\u00b1\u200915.1 years; 59.6% female), 32(61.5%) had PCD-related gene variants. CBF was reduced in 19\/20(95%) patients who underwent motility studies (mean CBF of 8.8\u2009\u00b1\u20092.7\u00a0Hz; normal 14.2\u2009\u00b1\u20091.0\u00a0Hz), and correlated significantly with FEV\n                      <jats:sub>1<\/jats:sub>\n                      (r\n                      <jats:sub>s<\/jats:sub>\n                      =0.65,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0017) and inversely with peak sputum neutrophils (r\n                      <jats:sub>s<\/jats:sub>\n                      =-0.62,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0097). Subnormal nNO levels (&lt;\u2009250 nL\/min) were observed in 12\/15(80%) patients; 3\/15(20%) were &lt;\u200977 nL\/min (PCD threshold). 5 patients showed FeNO discordance (&gt;\u200925 ppb). Cytokines associated with inflammasome activation were increased in sputum in majority of patients with PCD-related gene variants. Sputum-guided strategy and 7% hypertonic saline treatment enable significant inhaled corticosteroid doses reduction across the entire population and airway-eosinophilia subgroup (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0026 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0273). Oral corticosteroid doses were reduced in 6\/8(75%), and biologics were not initiated in 26\/32(81.3%). FEV\n                      <jats:sub>1<\/jats:sub>\n                      improved by 130\u2009\u00b1\u2009291mL,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0273.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Ciliary dyskinesias are prevalent in patients with severe asthma. Identifying ciliary motility disorders can guide effective treatment and reduce unnecessary biologics use in severe asthma when symptoms are infection-driven. Even variants of uncertain significance in PCD-related genes may be associated with airway infections due to ciliary dysfunction, proven by ciliary beat frequency analysis. nNO could be a useful screening tool, but its optimal cutoff in this population needs further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-026-01041-1","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:42:20Z","timestamp":1778240540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unrecognized ciliary motility disorders in neutrophilic severe asthma exacerbations"],"prefix":"10.1186","volume":"22","author":[{"given":"Sarita","family":"Thawanaphong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Gonzalez-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Kjarsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Venegas Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Fedosenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Dyment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Suray","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Adatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna","family":"Dolovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"issue":"4","key":"1041_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","volume":"135","author":"PW Hekking","year":"2015","unstructured":"Hekking PW, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896\u2013902.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1041_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/cea.13378","volume":"49","author":"H Backman","year":"2019","unstructured":"Backman H, Jansson SA, Stridsman C, Eriksson B, Hedman L, Eklund BM, et al. Severe asthma-a population study perspective. Clin Exp Allergy. 2019;49(6):819\u201328.","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"1041_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","volume":"179","author":"PM O\u2019Byrne","year":"2009","unstructured":"O\u2019Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179(1):19\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"1041_CR4","unstructured":"Difficult-To-Treat & Severe Asthma in Adolescent Patients. 2023. www.ginaasthma.org."},{"key":"1041_CR5","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fmed.2017.00158","volume":"4","author":"S Svenningsen","year":"2017","unstructured":"Svenningsen S, Nair P. Asthma endotypes and an overview of targeted therapy for asthma. Front Med. 2017;4:158.","journal-title":"Front Med"},{"issue":"11","key":"1041_CR6","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1111\/all.14976","volume":"76","author":"P Nair","year":"2021","unstructured":"Nair P, O\u2019Byrne PM. Medical algorithms: approach to adult asthma exacerbations. Allergy. 2021;76(11):3556\u20139.","journal-title":"Allergy"},{"issue":"5","key":"1041_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S2213-2600(21)00023-0","volume":"9","author":"P Nair","year":"2021","unstructured":"Nair P, Surette MG, Virchow JC. Neutrophilic asthma: misconception or misnomer? Lancet Respir Med. 2021;9(5):441\u20133.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"1041_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/all.13985","volume":"75","author":"E Sze","year":"2020","unstructured":"Sze E, Bhalla A, Nair P. Mechanisms and therapeutic strategies for non-T2 asthma. Allergy. 2020;75(2):311\u201325.","journal-title":"Allergy"},{"issue":"11","key":"1041_CR9","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.jaip.2021.09.031","volume":"9","author":"AA Petrov","year":"2021","unstructured":"Petrov AA, Adatia A, Jolles S, Nair P, Azar A, Walter JE. Antibody deficiency, chronic lung disease, and comorbid conditions: a case-based approach. J Allergy Clin Immunol Pract. 2021;9(11):3899\u2013908.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1041_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13223-022-00684-0","volume":"18","author":"E Priel","year":"2022","unstructured":"Priel E, Adatia A, Kjarsgaard M, Nair P. CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review. Allergy Asthma Clin Immunol. 2022;18(1):46.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"1041_CR11","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1164\/rccm.201805-0819ST","volume":"197","author":"AJ Shapiro","year":"2018","unstructured":"Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, et al. Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2018;197(12):e24\u201339.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1041_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MCP.0000000000001213","volume":"31","author":"RJ Reklow","year":"2025","unstructured":"Reklow RJ, Weir MJ, Dell SD. Primary ciliary dyskinesia: clinical manifestations and current diagnostic approaches. Curr Opin Pulm Med. 2025;31(6):635\u201343.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"1041_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaci.2010.05.046","volume":"126","author":"B Thomas","year":"2010","unstructured":"Thomas B, Rutman A, Hirst RA, Haldar P, Wardlaw AJ, Bankart J, et al. Ciliary dysfunction and ultrastructural abnormalities are features of severe asthma. J Allergy Clin Immunol. 2010;126(4):722-9.e2.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1041_CR14","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.jaci.2021.12.761","volume":"149","author":"VP Guntur","year":"2022","unstructured":"Guntur VP, Manka LA, Moore CM, Wynn E, Vladar EK, Alam R, et al. Refractory neutrophilic asthma and ciliary genes. J Allergy Clin Immunol. 2022;149(6):1970\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1041_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2025.100319","volume":"25","author":"R Collison","year":"2025","unstructured":"Collison R, Hyatali SA, Kamenova A, Rashed A, Riley D, Kumar K, et al. Primary ciliary dyskinesia: aetiology, diagnosis and clinical management. Clin Med. 2025;25(3):100319.","journal-title":"Clin Med"},{"key":"1041_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00745-2025","author":"A Shoemark","year":"2025","unstructured":"Shoemark A, Goutaki M, Kinghorn B, Ardura-Garcia C, Baz-Red\u00f3n N, Chilvers M, et al. European Respiratory Society and American Thoracic Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2025. https:\/\/doi.org\/10.1183\/13993003.00745-2025.","journal-title":"Eur Respir J"},{"issue":"25","key":"1041_CR17","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1056\/NEJMra1312543","volume":"370","author":"LG Biesecker","year":"2014","unstructured":"Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med. 2014;370(25):2418\u201325.","journal-title":"N Engl J Med"},{"issue":"21","key":"1041_CR18","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMra0907175","volume":"362","author":"WG Feero","year":"2010","unstructured":"Feero WG, Guttmacher AE, Collins FS. Genomic medicine\u2013an updated primer. N Engl J Med. 2010;362(21):2001\u201311.","journal-title":"N Engl J Med"},{"key":"1041_CR19","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01090-2016","author":"JS Lucas","year":"2017","unstructured":"Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.01090-2016.","journal-title":"Eur Respir J"},{"issue":"2","key":"1041_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2013","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2013;43(2):343\u201373.","journal-title":"Eur Respir J"},{"issue":"06","key":"1041_CR21","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1055\/s-2007-1009433","volume":"19","author":"E Pizzichini","year":"1998","unstructured":"Pizzichini E, Pizzichini MMM, Hargreave FE. Induced sputum in the management of asthma. Semin Respir Crit Care Med. 1998;19(06):581\u201392.","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"1041_CR22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00938-2018","volume":"53","author":"S Pavlidis","year":"2019","unstructured":"Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K, et al. \u201cT2-high\u201d in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J. 2019;53(1):1800938.","journal-title":"Eur Respir J"},{"issue":"10","key":"1041_CR23","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1164\/rccm.202109-2093ST","volume":"204","author":"SB Khatri","year":"2021","unstructured":"Khatri SB, Iaccarino JM, Barochia A, Soghier I, Akuthota P, Brady A, et al. Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2021;204(10):e97\u2013109.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1041_CR24","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1041_CR25","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01526-2016","volume":"49","author":"AL Coates","year":"2017","unstructured":"Coates AL, Wanger J, Cockcroft DW, Culver BH, Force t, Carlsen K-H, et al. ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests. Eur Respir J. 2017;49(5):1601526.","journal-title":"Eur Respir J"},{"issue":"6","key":"1041_CR26","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1183\/09031936.96.09061174","volume":"9","author":"E Pizzichini","year":"1996","unstructured":"Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J. 1996;9(6):1174\u201380.","journal-title":"Eur Respir J"},{"key":"1041_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/all.16011","author":"PP Hekking","year":"2024","unstructured":"Hekking PP, Zhang K, Garrido CPV, Lopez-Rodriguez R, Kjarsgaard M, Mukherjee M, et al. Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma. Allergy. 2024. https:\/\/doi.org\/10.1111\/all.16011.","journal-title":"Allergy"},{"key":"1041_CR28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202501-0186OC","author":"L Briggs","year":"2025","unstructured":"Briggs L, Brand\u00e3o C, Fleming A, Edwards M, Mueller S, Wilkinson S, et al. Non-coding DNA variants increase the genetic diagnostic yield in primary ciliary dyskinesia. Am J Respir Crit Care Med. 2025. https:\/\/doi.org\/10.1164\/rccm.202501-0186OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1041_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"1041_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells5040040","author":"A Yaghi","year":"2016","unstructured":"Yaghi A, Dolovich MB. Airway epithelial cell cilia and obstructive lung disease. Cells. 2016. https:\/\/doi.org\/10.3390\/cells5040040.","journal-title":"Cells"},{"issue":"4","key":"1041_CR31","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/thorax.55.4.314","volume":"55","author":"MA Chilvers","year":"2000","unstructured":"Chilvers MA, O\u2019Callaghan C. Analysis of ciliary beat pattern and beat frequency using digital high speed imaging: comparison with the photomultiplier and photodiode methods. Thorax. 2000;55(4):314\u20137.","journal-title":"Thorax"},{"issue":"2","key":"1041_CR32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1513\/AnnalsATS.201904-347OT","volume":"17","author":"AJ Shapiro","year":"2020","unstructured":"Shapiro AJ, Dell SD, Gaston B, O\u2019Connor M, Marozkina N, Manion M, et al. Nasal nitric oxide measurement in primary ciliary dyskinesia. A technical paper on standardized testing protocols. Ann Am Thorac Soc. 2020;17(2):e1\u201312.","journal-title":"Ann Am Thorac Soc"},{"key":"1041_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02031-2022","author":"N Beydon","year":"2023","unstructured":"Beydon N, Kouis P, Marthin JK, Latzin P, Colas M, Davis SD, et al. Nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesia: European Respiratory Society technical standard. Eur Respir J. 2023. https:\/\/doi.org\/10.1183\/13993003.02031-2022.","journal-title":"Eur Respir J"},{"key":"1041_CR34","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.2025.211.Abstracts.A7060","author":"S Nolasco","year":"2025","unstructured":"Nolasco S, Kjarsgaard M, Lauks S, Treleaven O, Ho T, Huang C, et al. Clinical remission by a comprehensive severe asthma management strategy guided by airway inflammometry and bioimaging. Am J Respir Crit Care Med. 2025. https:\/\/doi.org\/10.1164\/ajrccm.2025.211.Abstracts.A7060.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"1041_CR35","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.rmed.2012.04.001","volume":"106","author":"A Yaghi","year":"2012","unstructured":"Yaghi A, Zaman A, Cox G, Dolovich MB. Ciliary beating is depressed in nasal cilia from chronic obstructive pulmonary disease subjects. Respir Med. 2012;106(8):1139\u201347.","journal-title":"Respir Med"},{"issue":"5","key":"1041_CR36","doi-asserted-by":"publisher","first-page":"00220","DOI":"10.1183\/23120541.00220-2023","volume":"9","author":"C Kempeneers","year":"2023","unstructured":"Kempeneers C, Bonhiver R, Bricmont N, Pirotte M, Engelskirchen S, Benchimol L, et al. Ciliary dyskinesia in severe asthma is not affected by chronic mucus hypersecretion. ERJ Open Res. 2023;9(5):00220\u20132023.","journal-title":"ERJ Open Res"},{"issue":"1","key":"1041_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1164\/rccm.201607-1351OC","volume":"196","author":"A Shoemark","year":"2017","unstructured":"Shoemark A, Frost E, Dixon M, Ollosson S, Kilpin K, Patel M, et al. Accuracy of immunofluorescence in the diagnosis of primary ciliary dyskinesia. Am J Respir Crit Care Med. 2017;196(1):94\u2013101.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1041_CR38","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/ppul.24509","volume":"54","author":"R Vali","year":"2019","unstructured":"Vali R, Ghandourah H, Charron M, Nezhad KV, Omarkhail Y, Khazaee A, et al. Evaluation of the pulmonary radioaerosol mucociliary clearance scan as an adjunctive test for the diagnosis of primary ciliary dyskinesia in children. Pediatr Pulmonol. 2019;54(12):2021\u20137.","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"1041_CR39","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.chest.2021.02.006","volume":"159","author":"Y Guan","year":"2021","unstructured":"Guan Y, Yang H, Yao X, Xu H, Liu H, Tang X, et al. Clinical and genetic spectrum of children with primary ciliary dyskinesia in China. Chest. 2021;159(5):1768\u201381.","journal-title":"Chest"},{"key":"1041_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jpeds.2020.05.052","volume":"225","author":"Z Guo","year":"2020","unstructured":"Guo Z, Chen W, Wang L, Qian L. Clinical and genetic spectrum of children with primary ciliary dyskinesia in China. J Pediatr. 2020;225:157-65.e5.","journal-title":"J Pediatr"},{"key":"1041_CR41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01769-2023","author":"J Raidt","year":"2024","unstructured":"Raidt J, Riepenhausen S, Pennekamp P, Olbrich H, Amirav I, Athanazio RA, et al. Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.01769-2023.","journal-title":"Eur Respir J"},{"issue":"1","key":"1041_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/ajmg.c.31968","volume":"190","author":"R Kos","year":"2022","unstructured":"Kos R, Isra\u00ebls J, van Gogh CDL, Altenburg J, Diepenhorst S, Paff T, et al. Primary ciliary dyskinesia in Volendam: diagnostic and phenotypic features in patients with a CCDC114 mutation. Am J Med Genet C Semin Med Genet. 2022;190(1):89\u2013101.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"10","key":"1041_CR43","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1002\/ppul.24439","volume":"54","author":"C Kempeneers","year":"2019","unstructured":"Kempeneers C, Seaton C, Garcia Espinosa B, Chilvers MA. Ciliary functional analysis: beating a path towards standardization. Pediatr Pulmonol. 2019;54(10):1627\u201338.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"1041_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13223-023-00837-9","volume":"19","author":"BM Alotaibi","year":"2023","unstructured":"Alotaibi BM, Lopez Rodriguez R, Garrido CV, Gonzalez Bravo L, Khalidi N, Nair P. Autoinflammatory gene mutations associated with eosinophilia and asthma. Allergy Asthma Clin Immunol. 2023;19(1):76.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"1041_CR45","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00176-2022","author":"A Shoemark","year":"2022","unstructured":"Shoemark A, Griffin H, Wheway G, Hogg C, Lucas JS, Camps C, et al. Genome sequencing reveals underdiagnosis of primary ciliary dyskinesia in bronchiectasis. Eur Respir J. 2022. https:\/\/doi.org\/10.1183\/13993003.00176-2022.","journal-title":"Eur Respir J"},{"issue":"3","key":"1041_CR46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41436-020-01005-9","volume":"23","author":"EW Klee","year":"2021","unstructured":"Klee EW, Cousin MA, Pinto EVF, Morales-Rosado JA, Macke EL, Jenkinson WG, et al. Impact of integrated translational research on clinical exome sequencing. Genet Med. 2021;23(3):498\u2013507.","journal-title":"Genet Med"},{"key":"1041_CR47","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00681-2025","author":"LE Ostrowski","year":"2025","unstructured":"Ostrowski LE, Abu-Nasser S, Zeman KL, Leigh MW, Zariwala MA, Olivier KN, et al. Mucociliary and cough clearance in primary ciliary dyskinesia as affected by mutations in RSPH1 or DNAH5. ERJ Open Res. 2025. https:\/\/doi.org\/10.1183\/23120541.00681-2025.","journal-title":"ERJ Open Res"},{"issue":"2","key":"1041_CR48","doi-asserted-by":"publisher","DOI":"10.1088\/1752-7155\/8\/2\/026002","volume":"8","author":"C Krantz","year":"2014","unstructured":"Krantz C, Janson C, Borres MP, Nordvall L, Alving K, Malinovschi A. Nasal nitric oxide is associated with exhaled NO, bronchial responsiveness and poor asthma control. J Breath Res. 2014;8(2):026002.","journal-title":"J Breath Res"},{"key":"1041_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1486780","volume":"11","author":"S Thawanaphong","year":"2024","unstructured":"Thawanaphong S, Nair A, Volfson E, Nair P, Mukherjee M. IL-18 biology in severe asthma. Front Med. 2024;11:1486780.","journal-title":"Front Med"},{"key":"1041_CR50","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01966-2023","author":"L Perea","year":"2024","unstructured":"Perea L, Bottier M, Cant E, Richardson H, Dicker AJ, Shuttleworth M, et al. Airway IL-1\u03b2 is related to disease severity and mucociliary function in bronchiectasis. Eur Respir J. 2024. https:\/\/doi.org\/10.1183\/13993003.01966-2023.","journal-title":"Eur Respir J"},{"issue":"10","key":"1041_CR51","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1172\/JCI125669","volume":"129","author":"G Chen","year":"2019","unstructured":"Chen G, Sun L, Kato T, Okuda K, Martino MB, Abzhanova A, et al. IL-1\u03b2 dominates the promucin secretory cytokine profile in cystic fibrosis. J Clin Invest. 2019;129(10):4433\u201350.","journal-title":"J Clin Invest"},{"key":"1041_CR52","unstructured":"Reklow R, Dell S. AID-PCD: Assessing immunofluorescence for diagnosis of primary ciliary dyskinesia: Health Research BC; 2025 [Available from: https:\/\/healthresearchbc.ca\/award\/aid-pcd-assessing-immunofluorescence-for-diagnosis-of-primary-ciliary-dyskinesia\/"},{"issue":"1","key":"1041_CR53","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S2213-2600(23)00226-6","volume":"12","author":"FC Ringshausen","year":"2024","unstructured":"Ringshausen FC, Shapiro AJ, Nielsen KG, Mazurek H, Pifferi M, Donn KH, et al. Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial. Lancet Respir Med. 2024;12(1):21\u201333.","journal-title":"Lancet Respir Med"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-026-01041-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01041-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:32:09Z","timestamp":1782887529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-026-01041-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1186\/s13223-026-01041-1","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"7 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent for all procedures, including genetic testing, and for the use of their data for research purposes. The sputum assessment was approved by the Integrated Research Ethics Board of St. Joseph\u2019s Healthcare Hamilton (#11020, 14314, 3932, 11227). All data were recorded in electronic case report forms without identifiers. This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}